GlassScriptPhysician profile
Catherine Celeste Lewis
NPI 1750474904
$1,817.10
in general payments reported to CMS, 2019-2025
16 companies · $211 in 2025
The $211 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $289 · 2022: $440 · 2023: $582 · 2024: $295 · 2025: $211.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,088.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,087.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $997.96 | 2021-2025 | Descovy |
| Abbvie INC. | $248.58 | 2022-2024 | |
| Novo Nordisk INC | $201.58 | 2022-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $68.97 | 2022-2025 | Mounjaro |
| Viiv Healthcare Company | $59.21 | 2022-2024 | Apretude |
| Astrazeneca Pharmaceuticals LP | $35.52 | 2024-2025 | Airsupra |
| Medtronic, INC. | $31.27 | 2022 | |
| Exact Sciences Corporation | $30.53 | 2025 | Cologuard Collection Kit |
| Genentech USA, INC. | $25.29 | 2021 | |
| Sanofi-Aventis U.S. LLC | $20.82 | 2021 | |
| Janssen Pharmaceuticals, INC | $18.13 | 2021 | |
| Vistapharm, INC. | $17.88 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $16.49 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $15.83 | 2025 | Jardiance |
| Takeda Pharmaceuticals U.S.A., INC. | $14.59 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Xeris Pharmaceuticals, INC. | $14.45 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Catherine Lewis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.